Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing

NCT07319923 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07319923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07319923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 1, 2027
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-based screening, prostate cancer